{"transactions":[{"id":693118,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":25460,"kind":"person","name":"Grissinger Michael","position":1,"cik":"0001757601","reported_name":"Grissinger Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-07T20:11:15.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":2000,"price":2.11,"value":4220.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of August 3, 2027, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorata basis over the following two years."}],"balance_after":2000,"derivative":{"exercise_price":2.11,"exercise_date":"2027-08-03","expiration_date":"2036-08-03","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001493152-26-036577","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1757601/000149315226036577/ownership.xml","form_type":"4"}},{"id":729176,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":25460,"kind":"person","name":"Grissinger Michael","position":1,"cik":"0001757601","reported_name":"Grissinger Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-23T20:29:11.000Z","date":"2026-06-21","kind":"grant","planned":false,"acquired":true,"shares":4200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares shall vest in full on the earlier to occur of (i) the first anniversary of the grant date or (ii) the date of the next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on the Issuer's board of directors."}],"balance_after":4200,"derivative":{"exercise_price":8.1,"expiration_date":"2036-06-20","underlying":"Common Stock","underlying_shares":4200},"source":{"system":"sec-edgar","filing":"0001757601-26-000002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1757601/000175760126000002/ownership.xml","form_type":"4"}},{"id":734178,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":25460,"kind":"person","name":"Grissinger Michael","position":1,"cik":"0001757601","reported_name":"Grissinger Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-06-17T23:09:50.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":12555,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in full on June 16, 2027, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions."}],"balance_after":12555,"derivative":{"exercise_price":0.7293,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":12555},"source":{"system":"sec-edgar","filing":"0001104659-26-075286","document":"tm2618211-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1757601/000110465926075286/tm2618211-8_4seq1.xml","form_type":"4"}},{"id":734177,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":25460,"kind":"person","name":"Grissinger Michael","position":1,"cik":"0001757601","reported_name":"Grissinger Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-17T23:09:50.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":3135,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units which were granted on June 16, 2026, and which will vest and be settled in common stock on June 16, 2027, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions."}],"balance_after":6024,"source":{"system":"sec-edgar","filing":"0001104659-26-075286","document":"tm2618211-8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1757601/000110465926075286/tm2618211-8_4seq1.xml","form_type":"4"}},{"id":1118003,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":25460,"kind":"person","name":"Grissinger Michael","position":1,"cik":"0001757601","reported_name":"Grissinger Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2025-06-09T20:03:35.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":4185,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in full on June 5, 2026, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions."}],"balance_after":4185,"derivative":{"exercise_price":1.81,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":4185},"source":{"system":"sec-edgar","filing":"0001104659-25-057811","document":"tm2517366-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1757601/000110465925057811/tm2517366-3_4seq1.xml","form_type":"4"}},{"id":1118002,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":25460,"kind":"person","name":"Grissinger Michael","position":1,"cik":"0001757601","reported_name":"Grissinger Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-09T20:03:35.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":1045,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units which were granted on June 5, 2025, and which will vest and be settled in common stock on June 5, 2026, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions."}],"balance_after":2889,"source":{"system":"sec-edgar","filing":"0001104659-25-057811","document":"tm2517366-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1757601/000110465925057811/tm2517366-3_4seq1.xml","form_type":"4"}},{"id":1168391,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":25460,"kind":"person","name":"Grissinger Michael","position":1,"cik":"0001757601","reported_name":"Grissinger Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-21T20:11:32.000Z","date":"2025-04-17","kind":"grant","planned":false,"acquired":true,"shares":70200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares shall vest in thirty-six (36) equal monthly installments following April 17, 2025; provided, however, that all vesting shall cease if the Reporting Person resigns from the Issuer's Board of Directors or otherwise ceases to serve as a director of the Issuer."}],"balance_after":70200,"derivative":{"exercise_price":0.5258,"expiration_date":"2035-04-16","underlying":"Common Stock","underlying_shares":70200},"source":{"system":"sec-edgar","filing":"0000950170-25-056294","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1757601/000095017025056294/ownership.xml","form_type":"4"}},{"id":1463170,"issuer":{"id":7692,"kind":"organization","name":"Akari Therapeutics Plc","symbol":"AKTX"},"owners":[{"id":25460,"kind":"person","name":"Grissinger Michael","position":1,"cik":"0001757601","reported_name":"Grissinger Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-02T20:30:11.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":5000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The stock options have an exercise price of $0.001395 per ordinary share, par value $0.0001 per share (\"Ordinary Share\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Non-qualified stock option granted under the Issuer's 2023 Equity Incentive Plan. One-hundred percent (100%) of the stock option vests and becomes exercisable on the date of the Issuer's 2025 Annual General Meeting of Shareholders, subject to continued service with the Issuer."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents 2,000 Ordinary Shares."}],"balance_after":5000000,"derivative":{"exercise_price":0.0014,"expiration_date":"2034-06-28","underlying":"Ordinary Shares, par value $0.0001 per share","underlying_shares":5000000},"source":{"system":"sec-edgar","filing":"0000950170-24-080538","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1757601/000095017024080538/ownership.xml","form_type":"4"}},{"id":1472125,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":25460,"kind":"person","name":"Grissinger Michael","position":1,"cik":"0001757601","reported_name":"Grissinger Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2024-06-21T20:16:34.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":4185,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in full on June 20, 2025, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions."}],"balance_after":4185,"derivative":{"exercise_price":4.07,"expiration_date":"2034-06-20","underlying":"Common Stock","underlying_shares":4185},"source":{"system":"sec-edgar","filing":"0001104659-24-073936","document":"tm2417666-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1757601/000110465924073936/tm2417666-2_4seq1.xml","form_type":"4"}},{"id":1472124,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":25460,"kind":"person","name":"Grissinger Michael","position":1,"cik":"0001757601","reported_name":"Grissinger Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-21T20:16:34.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":1045,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units which were granted on June 20, 2024, and which will vest and be settled in common stock on June 20, 2025, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions."}],"balance_after":1844,"source":{"system":"sec-edgar","filing":"0001104659-24-073936","document":"tm2417666-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1757601/000110465924073936/tm2417666-2_4seq1.xml","form_type":"4"}},{"id":1797766,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":25460,"kind":"person","name":"Grissinger Michael","position":1,"cik":"0001757601","reported_name":"Grissinger Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2023-08-25T01:51:56.000Z","date":"2023-08-23","kind":"grant","planned":false,"acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in full on August 23, 2024, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions."}],"balance_after":2000,"derivative":{"exercise_price":3.65,"expiration_date":"2033-08-23","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001104659-23-095020","document":"tm2324788-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1757601/000110465923095020/tm2324788-7_4seq1.xml","form_type":"4"}},{"id":1797765,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":25460,"kind":"person","name":"Grissinger Michael","position":1,"cik":"0001757601","reported_name":"Grissinger Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-25T01:51:56.000Z","date":"2023-08-23","kind":"grant","planned":false,"acquired":true,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units which were granted on August 23, 2023, and which will vest and be settled in common stock on August 23, 2024, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions."}],"balance_after":799,"source":{"system":"sec-edgar","filing":"0001104659-23-095020","document":"tm2324788-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1757601/000110465923095020/tm2324788-7_4seq1.xml","form_type":"4"}},{"id":2199117,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":25460,"kind":"person","name":"Grissinger Michael","position":1,"cik":"0001757601","reported_name":"Grissinger Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to Buy)","published_at":"2022-08-01T21:02:13.000Z","date":"2022-07-28","kind":"grant","acquired":true,"shares":29575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in full on July 28, 2023, subject to the reporting person's continued service on the Issuer's board of directors through and including the\napplicable vesting date and subject to acceleration under certain conditions."}],"balance_after":29575,"derivative":{"exercise_price":1.09,"expiration_date":"2032-07-28","underlying":"Common Stock","underlying_shares":29575},"source":{"system":"sec-edgar","filing":"0001104659-22-084764","document":"tm2222147-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1757601/000110465922084764/tm2222147-4_4seq1.xml","form_type":"4"}},{"id":2199116,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":25460,"kind":"person","name":"Grissinger Michael","position":1,"cik":"0001757601","reported_name":"Grissinger Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-01T21:02:13.000Z","date":"2022-07-28","kind":"grant","acquired":true,"shares":5995,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units which were granted on July 28, 2022, and which will vest and be settled in common stock on July 28, 2023,\nsubject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to\nacceleration under certain conditions."}],"balance_after":5995,"source":{"system":"sec-edgar","filing":"0001104659-22-084764","document":"tm2222147-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1757601/000110465922084764/tm2222147-4_4seq1.xml","form_type":"4"}},{"id":3120658,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":25460,"kind":"person","name":"Grissinger Michael","position":1,"cik":"0001757601","reported_name":"Grissinger Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-05T20:33:12.000Z","date":"2020-06-03","kind":"grant","acquired":true,"shares":14414,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 3, 2020 with respect to 14,414 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant."}],"balance_after":14414,"derivative":{"exercise_price":2.23,"expiration_date":"2030-06-02","underlying":"Common Stock","underlying_shares":14414},"source":{"system":"sec-edgar","filing":"0000899243-20-015458","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1757601/000089924320015458/doc4.xml","form_type":"4"}},{"id":3533737,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":25460,"kind":"person","name":"Grissinger Michael","position":1,"cik":"0001757601","reported_name":"Grissinger Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-09T22:48:12.000Z","date":"2019-05-08","kind":"grant","acquired":true,"shares":14414,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 8, 2019 with respect to 14,414 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant."}],"balance_after":14414,"derivative":{"exercise_price":7.99,"expiration_date":"2029-05-07","underlying":"Common Stock","underlying_shares":14414},"source":{"system":"sec-edgar","filing":"0000899243-19-012923","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1757601/000089924319012923/doc4.xml","form_type":"4"}},{"id":3772876,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":25460,"kind":"person","name":"Grissinger Michael","position":1,"cik":"0001757601","reported_name":"Grissinger Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-11-06T21:18:55.000Z","date":"2018-11-05","kind":"grant","acquired":true,"shares":28828,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"33% of the shares shall vest on November 5, 2019, with the remainder vesting ratably monthly thereafter for a period of two (2) years."}],"balance_after":28828,"derivative":{"exercise_price":11.82,"expiration_date":"2028-11-04","underlying":"Common Stock","underlying_shares":28828},"source":{"system":"sec-edgar","filing":"0000899243-18-028313","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1757601/000089924318028313/doc4.xml","form_type":"4"}}]}